Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Brian Conway"'
Autor:
Jordan J. Feld, Fernanda Q. Onofrio, Alnoor Ramji, Alexander Wong, Brian Conway, Joshua Booth, Izza Sattar, Sergio Borgia, Curtis Cooper, Leslie B. Lilly, Marie-Louise Vachon, Samuel Lee, Heidy Morales
Publikováno v:
Clinical Infectious Diseases. 72:e799-e805
Background Despite the current highly effective therapies with direct-acting antiviral agents (DAAs), some patients with chronic hepatitis C virus (HCV) infection still do not achieve sustained virological response (SVR) and require retreatment. Sofo
Autor:
Matt Driedger, Sam Lee, Brian Conway, Curtis Cooper, Alnoor Ramji, Jordan J. Feld, Alexander Wong, Lisa Barrett, Ed Tam, Sergio Borgia, Dan Smyth, Marie-Louise Vachon
Publikováno v:
Can Liver J
BACKGROUND: Alcohol use and hepatitis C virus (HCV) are two leading causes of liver disease. Alcohol use is prevalent among the HCV-infected population and accelerates the progression of HCV-related liver disease. Despite barriers to care faced by HC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3dc889a40028c6388bb8540df08231db
https://europepmc.org/articles/PMC9202771/
https://europepmc.org/articles/PMC9202771/
Autor:
Amanda Erratt, Jordan J. Feld, Curtis Cooper, Gail V. Matthews, Sione Crawford, Adrian Dunlop, David R. Shaw, Catherine A.M. Stedman, Kathy Petoumenos, Tanya L. Applegate, Margaret Hellard, Phillipa Marks, Brian Conway, Erika Castro, Alberto Moriggia, Evan B Cunningham, Jeff Powis, Ian Kronborg, Gregory J. Dore, Patrick Schmid, Edward Gane, Christopher S. Fraser, Julie Bruneau, Olav Dalgard, Jean-Pierre Daulouède, Karine Lacombe, Jason Grebely, Philip Bruggmann, Behzad Hajarizadeh
Publikováno v:
International Journal of Drug Policy. 62:94-103
Background: Direct-acting antiviral therapy for hepatitis C virus (HCV) infection is safe and effective, but there are little data among people who have recently injected drugs. This study evaluated the efficacy, and safety of paritaprevir/ritonavir,
Autor:
Phillip Read, Alain H. Litwin, Karine Lacombe, Simplify, D Feat study groups, Gail V. Matthews, Margaret Hellard, Philippa Marks, Curtis Cooper, Julie Bruneau, Evan B Cunningham, Jordan J. Feld, John F. Dillon, Janaki Amin, David R. Shaw, Jeff Powis, Brian Conway, Gregory J. Dore, Olav Dalgard, Christopher S. Fraser, Edward Gane, Jason Grebely, Philip Bruggmann, Behzad Hajarizadeh
Publikováno v:
Cunningham, Evan B; Hajarizadeh, Behzad; Amin, Janaki; Litwin, Alain H; Gane, Edward; Cooper, Curtis; Lacombe, Karine; Hellard, Margaret; Read, Phillip; Powis, Jeff; Dalgard, Olav; Bruneau, Julie; Matthews, Gail V; Feld, Jordan J; Dillon, John F; Shaw, David; Bruggmann, Philip; Conway, Brian; Fraser, Chris; Marks, Philippa; ... (2020). Adherence to Once-daily and Twice-daily Direct-acting Antiviral Therapy for Hepatitis C Infection Among People With Recent Injection Drug Use or Current Opioid Agonist Therapy. Clinical infectious diseases, 71(7), e115-e124. Oxford University Press 10.1093/cid/ciz1089
Background This study investigated adherence and associated factors among people with recent injection drug use (IDU) or current opioid agonist therapy (OAT) and compared once-daily to twice-daily hepatitis C virus (HCV) direct-acting antiviral (DAA)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::678977e8deedcd62698c43c32205e51c
https://boris.unibe.ch/148178/1/ciz1089.pdf
https://boris.unibe.ch/148178/1/ciz1089.pdf
Autor:
Brian Conway, Alexander Wong, Marco Puglia, Keyur Patel, Kris Stewart, Sergio Borgia, Jodi Halsey-Brandt, Lucie Deshaies, Samuel S. Lee, Benoit Trottier, Karen Doucette, Curtis Cooper, Eric M. Yoshida, Bahe Rajendran, Alnoor Ramji, Christopher S. Fraser, Julie Tremblay, Peter Ghali, Janie B Trepanier, Keith Tsoi, Gisela Macphail, Edward Tam
Publikováno v:
Can Liver J
Background: Canada was the first country to approve elbasvir/grazoprevir (EBR/GZR) for the treatment of chronic HCV infection for genotypes 1 and 4 with or without ribavirin and genotype 3 with sofosbuvir, with no recommendation for baseline resistan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95d5a12e3f0a30510b7eaac85095f7ca
https://europepmc.org/articles/PMC9202709/
https://europepmc.org/articles/PMC9202709/
Autor:
Douglas Cunningham, D. Ward, Mamta K. Jain, Faiza Ajana, Magda Opsomer, Anita Rachlis, Sharon Walmsley, Frank A. Post, Anders Blaxhult, Amanda Clarke, M. J. Galindo, Marcel Stoeckle, P.-M. Girardy, Karam Mounzer, David Shamblaw, U. F. Bredeek, L. Bhatti, J. J. Eron, Andrew Ustianowski, Mar Gutierrez, John Jezorwski, Javier O Morales-Ramirez, Antonio Rivero, M.A. Johnson, Gatell Jm, Erika Van Landuyt, Stéphane De Wit, A. Wilkin, Laurent Cotte, Cheryl McDonald, D. Murphy, Cynthia Brinson, Romana Petrovic, Olayemi Osiyemi, J. de Vente, I. Poizot-Martin, Juan Berenguer, Robin Dretler, J. Bailey, B. Rashbaum, Moti Ramgopal, A. Scribner, Yazdan Yazdanpanah, Eric Florence, A. Piekarska, Brian Gazzard, Chloe Orkin, W. Halota, Gary Richmond, Jacques Reynes, C. Ricart, C. Lucasti, Ignacio Pérez-Valero, Jason Brunetta, S. Shafran, Daniel Podzamczer, Franco Antonio Felizarta, Claudia Martorell, F. Post, Peter Ruane, Edwin DeJesus, J. Portilla Sogorb, C. Orkin, K. Tashima, Federico Pulido, Bernard Vandercam, F. Pulido, José L. Casado, Christine Katlama, Kimberley Brown, J Gasiorowski, A. Witor, Joseph J. Eron, Brian Conway, Andri Rauch, Jose R. Arribas, Michel Moutschen, H. Olivet, A. Scarsella, Leo Flamholc, A. Horban, D. Cunningham, Ronald Nahass, Félix Gutiérrez, G. Huhn, W.K. Henry, A. Thalme, S De Wit, Jan Fehr, Debbie Hagins, José Antonio Iribarren, J.-M. Molina, S. Henn, F Raffi, Juan A. Pineda, Marina B. Klein, Eugenia Negredo, Hernando Knobel, J. Slim, P. Benson, L. Waters, E. Teicher, Linos Vandekerckhove, Craig A. Dietz, Magnus Gisslén, Joel E. Gallant, J. Gathe, P. Shalit, D. Prelutsky, G. Voskuhl, D. Rey, E. Van Wijngaerden, Anthony Mills, Erkki Lathouwers, Carl J. Fichtenbaum, I. Brar, Gordon Crofoot, Veerle Hufkens, I. Santos Gil
Publikováno v:
Antiviral Research
Antiviral Research, Elsevier Masson, 2019, 170, pp.104543. ⟨10.1016/j.antiviral.2019.104543⟩
ANTIVIRAL RESEARCH
Antiviral Research, 2019, 170, pp.104543. ⟨10.1016/j.antiviral.2019.104543⟩
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Dipòsit Digital de la UB
Universidad de Barcelona
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
Antiviral research, Vol. 170, p. 104543 [1-11] (2019)
Antiviral Research, Elsevier Masson, 2019, 170, pp.104543. ⟨10.1016/j.antiviral.2019.104543⟩
ANTIVIRAL RESEARCH
Antiviral Research, 2019, 170, pp.104543. ⟨10.1016/j.antiviral.2019.104543⟩
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Dipòsit Digital de la UB
Universidad de Barcelona
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
Antiviral research, Vol. 170, p. 104543 [1-11] (2019)
Darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) 800/150/200/10 mg was investigated through 96 weeks in EMERALD (NCT02269917). Virologically-suppressed, HIV-1-positive treatment-experienced adults (previous non-darunavir virologic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::017eb51bc97390ae19e12fb2aea5fdc8
http://hdl.handle.net/2445/171213
http://hdl.handle.net/2445/171213
Autor:
Sophie Quiene, Behzad Hajarizadeh, Brian Conway, Julie Bruneau, David R. Shaw, Tanya L. Applegate, Martin Weltman, Philip Bruggmann, Philippa Marks, Jason Grebely, Tracy Swan, Håvard Midgard, Margaret Hellard, Olav Dalgard, Geert Robaeys, Janaki Amin, Evan B Cunningham, Suzanne Bourgeois, Gregory J. Dore, Graham R. Foster, Markus Backmund, Cornelia Staehelin, Adrian Dunlop
Publikováno v:
International Journal of Drug Policy. 47:177-186
Background There are few data on treatment for hepatitis C virus (HCV) infection among people with ongoing injecting drug use. This study evaluated the efficacy of response-guided therapy for chronic HCV genotypes 2/3 infection among people with ongo
Autor:
Gail V. Matthews, Philip Bruggmann, Margaret Hellard, Julie Bruneau, Sophie Quiene, Alain H. Litwin, P. Marks, Jeff Powis, Behzad Hajarizadeh, Catherine A.M. Stedman, Brian Conway, Andreea Adelina Artenie, Philip Read, Evan B Cunningham, Janaki Amin, Gregory J. Dore, Olav Dalgard, Jordan J. Feld, Karine Lacombe, Jason Grebely, Amanda Erratt, Curtis Cooper
Publikováno v:
Clin Infect Dis
Clinical Infectious Diseases
Clinical Infectious Diseases, 2020, 70 (11), pp.2369--2376. ⟨10.1093/cid/ciz633⟩
Clinical Infectious Diseases
Clinical Infectious Diseases, 2020, 70 (11), pp.2369--2376. ⟨10.1093/cid/ciz633⟩
Background In many settings, recent or prior injection drug use remains a barrier to accessing direct-acting antiviral treatment (DAA) for hepatitis C virus (HCV) infection. We examined patterns of drug and alcohol use and injection equipment sharing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4130302b42bca5e296d2230a4dd23cd2
https://europepmc.org/articles/PMC7245153/
https://europepmc.org/articles/PMC7245153/
Autor:
Pedro Cahn, Juan Sierra Madero, José Ramón Arribas, Andrea Antinori, Roberto Ortiz, Amanda E Clarke, Chien-Ching Hung, Jürgen K Rockstroh, Pierre-Marie Girard, Jörg Sievers, Choy Man, Alexander Currie, Mark Underwood, Allan R Tenorio, Keith Pappa, Brian Wynne, Anna Fettiplace, Martin Gartland, Michael Aboud, Kimberly Smith, Lidia Cassetti, Daniel David, Laura Figueras, Marcelo Losso, Gustavo Lopardo, Sergio Lupo, Norma Porteiro, Marisa Sánchez, Mark Bloch, David Cooper, Robert Finlayson, Anthony Kelleher, Kenneth Koh, David Lewis, James McMahon, Richard Moore, Norman Roth, Matthew Shields, Stephane De Wit, Eric Florence, Jean-Christophe Goffard, Remy Demeester, Patrick Lacor, Bernard Vandercam, Linos Vandekerckhove, Jonathan Angel, Jean-Guy Baril, Brian Conway, Alexandra De Pokomandy, Jason Szabo, Sharon Walmsley, Olivier Bouchaud, Christian Chidiac, Pierre Delobel, Cecile Goujard, Christine Katlama, Jean-Michel Molina, Gilles Pialoux, Patrick Philibert, Johannes Bogner, Stefan Esser, Ivanka Krznaric, Clara Lehmann, Christoph Spinner, Hans-Jurgen Stellbrink, Christoph Stephan, Albrecht Stoehr, Enrico Barchi, Pietro Caramello, Francesco Castelli, Anna Maria Cattelan, Antonella D'Arminio Monforte, Antonio Di Biagio, Giovanni Di Perri, Andrea Gori, Franco Maggiolo, Barbara Menzaghi, Guglielmo Migliorino, Cristina Mussini, Giovanni Penco, Massimo Puoti, Giuliano Rizzardini, Roberto Gulminetti, Adriano Lazzarin, Tiziano Quirino, Laura Sighinolfi, Pierluigi Viale, Gerardo Amaya Tapia, Jaime Andrade Villanueva, Enrique R Granados Reyes, Alma Perez Rios, Mario Santoscoy Gomez, Jan Den Hollander, Bart Rijnders, José A Hidalgo, Luis Hercilla Vasquez, Luis Illescas, Anita Olczak, Kamal Mansinho, Patricia Paula Correia Pacheco, Eugénio Teófilo, Jose Saraiva da Cunha, Rui Sarmento e Castro, Rosário Serrão, Manuela Arbune, Cristian Jianu, Anca Oprea, Liliana Preotescu, Liviu-Jany Prisacariu, Elena Belonosova, Olga Borodkina, Oxana Chernova, Natalia Gankina, Svetlana Kizhlo, Valeriy Kulagin, Nadezhda Kurina, Firaya Nagimova, Vadim Pokrovsky, Elena Ryamova, Evgeny Voronin, Alexey Yakovlev, Richard Kaplan, Sun Hee Lee, Shin-Woo Kim, Sang-Il Kim, Woo Joo Kim, Antonio Antela Lopez, Jose L Casado Osorio, Manuel A Castaño Carracedo, Ignacio De Los Santos Gil, Vicente Estrada Perez, Vicenç Falco Ferrer, Luis Force, Maria Jose Galinda Puerto, Miguel Garcia Deltoro, Josep M Gatell, Miguel A Goenaga Sanchez, Ana González Cordón, Hernando Knobel, Juan Carlos Lopez Bernaldo de Quiros, Juan E Losa Garcia, Mar Masia, Marta Montero-Alsonso, Antonio Ocampo Hermida, Juan Pasquau Liaño, Joaquin Portilla Sogorb, Federico Pulido Ortega, Antonio Rivera Roman, Jose Ramon Santos Fernandez, Rafael Torres Perea, Jesus Troya Garcia, Pompeyo Viciana Fernandez, Alexandra Calmy, Christoph Hauser, Jan Fehr, Shu-Hsing Cheng, Wen-Chien Ko, Hsi-Hsun Lin, Po-Liang Lu, Yu-Ting Tseng, Ning-Chi Wang, Wing-Wai Wong, Chia-Jui Yang, Roberto Arduino, Paul Benson, Mezgebe Berhe, Fritz Bredeek, Cynthia Brinson, Thomas Campbell, Gordon Crofoot, Douglas Cunningham, Edwin DeJesus, Robin Dretler, Joseph Eron, Kenneth Fife, Carl Fichtenbaum, Jason Flamm, Deborah Goldstein, Samir Gupta, Debbie Hagins, Margaret Hoffman-Terry, Dushyantha Jayaweera, Clifford Kinder, Daniel Klein, Cheryl McDonald, Anthony Mills, Ronald Nahass, Olayemi Osiyemi, Edgar Overton, David Parks, David Prelutsky, Moti Ramgopal, Shannon Schrader, Beverly Sha, Gary Simon, James Sims, Daniel Skiest, Jihad Slim, Karen Tashima, Blair Thedinger, Brian Gazzard, Julie Fox, Margaret Johnson, Stephen Kegg, Saye Khoo, Charles Mazhude, Chloe Orkin, Gabriel Schembri, Andrew Ustianowski
Publikováno v:
The Lancet, 393(10167), 143-155. Elsevier Ltd.
Summary Background Effective two-drug regimens could decrease long-term drug exposure and toxicity with HIV-1 antiretroviral therapy (ART). We therefore aimed to evaluate the efficacy and safety of a two-drug regimen compared with a three-drug regime
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ad70b60db548619c808fac0879d6106
https://hdl.handle.net/11380/1221490
https://hdl.handle.net/11380/1221490
Autor:
Gary A. Baker, Brian Conway, Sharad Kumar Yadav, Juan C. Araque, Mark Maroncelli, Anne Kaintz, Christopher A. Rumble, Claudio J. Margulis
Publikováno v:
ResearcherID
Temperature-dependent (2)H longitudinal spin relaxation times (T1) of dilute benzene-d6 in 1-butyl-3-methylimidazolium tetrafluoroborate ([Im41][BF4]) and two deuterated variants of the 1-ethyl-3-methylimidazolium cation (Im21(+)-d1 and Im21(+)-d6) i